PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Current Assets (2021 - 2026)

PepGen (PEPG) posted Current Assets of $134.3 million for Q1 2026, down 11.06% sequentially from $151.0 million in Q4 2025, and up 32.88% YoY from $101.0 million in Q1 2025.

Analysis

PepGen (PEPG) Current Assets (2021 - 2026) Analysis & Trends

PepGen has reported Current Assets for 6 years, with the latest figure at $134.3 million in Q1 2026.

  • Quarterly Current Assets rose 32.88% year-over-year to $134.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.3 million (up 32.88% YoY) and the FY2025 annual result came in at $151.0 million, up 21.98% from the prior year.
  • Current Assets slipped to $134.3 million in Q1 2026 per PEPG's latest filing, from $151.0 million in the prior quarter.
  • Over five years, Current Assets peaked at $226.5 million in Q2 2022 and troughed at $77.5 million in Q2 2025.
  • A 5-year average of $149.7 million and a median of $150.4 million in 2023 frame the typical range for Current Assets.
  • The sharpest annual moves came in 2023 and 2025: Current Assets soared 34.06% in 2023, then slumped 52.98% in 2025.
  • Over 5 years, Current Assets stood at $186.1 million in 2022, then tumbled by 39.45% to $112.7 million in 2023, then grew by 9.84% to $123.8 million in 2024, then climbed by 21.98% to $151.0 million in 2025, then decreased by 11.06% to $134.3 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $134.3 million, $151.0 million, and $166.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 PepGen 217.99 Mn 217.99 Mn - 120.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.33 Mn
Mar 31, 2026 134.27 Mn
Dec 31, 2025 150.96 Mn
Sep 30, 2025 166.21 Mn
Jun 30, 2025 77.49 Mn
Mar 31, 2025 101.05 Mn
Dec 31, 2024 123.76 Mn
Sep 30, 2024 142.37 Mn
Jun 30, 2024 164.78 Mn
Mar 31, 2024 177.62 Mn
Dec 31, 2023 112.68 Mn
Sep 30, 2023 133.09 Mn
Jun 30, 2023 150.38 Mn
Mar 31, 2023 168.47 Mn
Dec 31, 2022 186.08 Mn
Sep 30, 2022 204.25 Mn
Jun 30, 2022 226.48 Mn
Mar 31, 2022 125.67 Mn
Dec 31, 2021 139.99 Mn